Compare Citius Pharmaceuticals Inc (CTXR) vs First Citizens BancShares Inc (FCNCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs First Citizens BancShares Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $21.25M), while First Citizens BancShares Inc trades at $2,270.44 (market cap $25.26B). The key difference: First Citizens BancShares Inc is far larger — about 1188.7× Citius Pharmaceuticals Inc's market cap, and First Citizens BancShares Inc pays a 0.37% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | FCNCA | |
|---|---|---|
Market Cap | $21.25M | $25.26B |
Sector | Health | Sector/Thematic |
52-Week High | $1.82 | $2.27K |
52-Week Low | $0.48 | $1.64K |
Enterprise Value | $17.47M | — |
Dividend Yield | — | 0.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →
